Revolutionizing anti-HER2 therapies for extrahepatic cholangiocarcinoma and gallbladder cancer: Current advancements and future perspectives
- DOI
- 10.1016/j.ejca.2024.113564
- Published
- 2024-03
- Container
- European Journal of Cancer
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.ejca.2024.113564,
title = {Revolutionizing anti-HER2 therapies for extrahepatic cholangiocarcinoma and gallbladder cancer: Current advancements and future perspectives},
author = {Britte H.E.A ten Haaft and Manuel Pedregal and Javier Prato and Heinz-Josef Klümpen and Victor Moreno and Angela Lamarca},
year = {2024},
journal = {European Journal of Cancer},
doi = {10.1016/j.ejca.2024.113564},
url = {https://doi.org/10.1016/j.ejca.2024.113564}
}RIS
TY - JOUR TI - Revolutionizing anti-HER2 therapies for extrahepatic cholangiocarcinoma and gallbladder cancer: Current advancements and future perspectives AU - Britte H.E.A ten Haaft AU - Manuel Pedregal AU - Javier Prato AU - Heinz-Josef Klümpen AU - Victor Moreno AU - Angela Lamarca PY - 2024 JO - European Journal of Cancer DO - 10.1016/j.ejca.2024.113564 UR - https://doi.org/10.1016/j.ejca.2024.113564 ER -
APA
Haaft, B. H. T., Pedregal, M., Prato, J., Klümpen, H., Moreno, V., & Lamarca, A. (2024). Revolutionizing anti-HER2 therapies for extrahepatic cholangiocarcinoma and gallbladder cancer: Current advancements and future perspectives. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2024.113564
Source records
- crossref · retrieved 2026-09-27T10:56:01.600Z